Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Precision Medicine for Every Child With Cancer
Protocol ID
ZERO2
Disease (Sub Disease)
All tumour types
Diagnosis Stage
Newly diagnosed
Relapsed/Refractory
Relapsed/Refractory
Location
NSW
Sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Collaborators
Sydney Children's Hospitals Network
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
Sydney Children's Hospital
Sydney Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
0 Years to 25 Years
International registry ID's
NCT05504772
| Study Title | Precision Medicine for Every Child With Cancer |
|---|---|
| Protocol ID | ZERO2 |
| Disease (Sub Disease) | All tumour types |
| Diagnosis Stage | Newly diagnosed Relapsed/Refractory |
| Location | NSW |
| Sponsor | Australian & New Zealand Children's Haematology/Oncology Group |
| Collaborators | Sydney Children's Hospitals Network |
| Links | https://clinicaltrials.gov/ct2/show/NCT05504772 |
| Trial Status | Open |
| Trial Open Date | 16/12/2022 |
| Sites | The Children's Hospital at Westmead / Sydney Children's Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | 0 Years to 25 Years |
| International registry ID's | NCT05504772 |